These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7917251)

  • 21. Intercellular Communication between Keratinocytes and Fibroblasts Induces Local Osteoclast Differentiation: a Mechanism Underlying Cholesteatoma-Induced Bone Destruction.
    Iwamoto Y; Nishikawa K; Imai R; Furuya M; Uenaka M; Ohta Y; Morihana T; Itoi-Ochi S; Penninger JM; Katayama I; Inohara H; Ishii M
    Mol Cell Biol; 2016 Jun; 36(11):1610-20. PubMed ID: 27001307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein.
    Huang CC; Chen CT; Huang TS; Shinoda H
    Eur Arch Otorhinolaryngol; 1996; 253(7):385-9. PubMed ID: 8891480
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HB-EGF expression as a potential biomarker of acquired middle ear cholesteatoma.
    Xie S; Wang X; Ren H; Liu X; Ren J; Liu W
    Acta Otolaryngol; 2017 Aug; 137(8):797-802. PubMed ID: 28498080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nature of the epithelium in acquired cholesteatoma: Part 3--Cytokeratin patterns in aural epithelial and cholesteatoma cells grown in cell culture.
    Lee RJ; Sidey C; Narula AA; James RF
    Clin Otolaryngol Allied Sci; 1994 Dec; 19(6):516-20. PubMed ID: 7534665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Molecular control of bone resorption in chronic otitis media with cholesteatoma].
    Kuczkowski J; Kobierska-Gulida G; Izycka-Swieszewska E; Potocka M; Mikaszewski B; Sierszeń W
    Otolaryngol Pol; 2010; 64(4):219-24. PubMed ID: 20873097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro.
    Yan SD; Huang CC
    Ann Otol Rhinol Laryngol; 1991 Feb; 100(2):157-61. PubMed ID: 1671546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The research progress of keratin's roles in the pathology of middle ear cholesteatoma].
    Feng YS; Si Y; Zhang ZG
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Nov; 54(11):870-874. PubMed ID: 31795552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The biological function of platelet-derived growth factor-BB in the osteoblast-osteoclast co-culture system].
    Zhang Z; Chen J; Jin D
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):425-8. PubMed ID: 11798912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Bcl-xL protein in differentiation and apoptosis of human middle ear cholesteatoma epithelium.
    Kojima H; Miyazaki H; Tanaka Y; Shiwa M; Koga T; Moriyama H
    Arch Otolaryngol Head Neck Surg; 1999 Jul; 125(7):738-42. PubMed ID: 10406309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. J774A.1 macrophage cell line produces PDGF-like and non-PDGF-like growth factors for bone cells.
    Cheng SL; Rifas L; Shen V; Tong B; Pierce G; Deuel T; Peck WA
    J Bone Miner Res; 1987 Oct; 2(5):467-74. PubMed ID: 3455630
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokines expressed in multinucleated cells: Paget's disease and giant cell tumors versus normal bone.
    Mills BG; Frausto A
    Calcif Tissue Int; 1997 Jul; 61(1):16-21. PubMed ID: 9192505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor expression in middle ear cholesteatoma.
    Chi HP; Ho KY; Chai CY; Ta CF; Wang LF; Lee KW; Kuo WR; Wu SC; Tsai SM
    Kaohsiung J Med Sci; 2004 Jan; 20(1):6-11. PubMed ID: 15481560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of cytokines in cholesteatoma tissue.
    Marenda SA; Aufdemorte TB
    Otolaryngol Head Neck Surg; 1995 Mar; 112(3):359-68. PubMed ID: 7532849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma.
    Ahn JM; Huang CC; Abramson M
    Otolaryngol Head Neck Surg; 1990 Oct; 103(4):527-36. PubMed ID: 2174138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma.
    Hansen T; Unger RE; Gaumann A; Hundorf I; Maurer J; Kirkpatrick CJ; Kriegsmann J
    Mod Pathol; 2001 Dec; 14(12):1226-31. PubMed ID: 11743044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholesteatoma in children: histopathologic findings in middle ear ossicles.
    Quaranta A; Bartoli R; Lozupone E; Resta L; Iurato S
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(5):296-8. PubMed ID: 8587786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cholesteatoma-associated fibroblasts modulate epithelial growth and differentiation through KGF/FGF7 secretion.
    Raffa S; Leone L; Scrofani C; Monini S; Torrisi MR; Barbara M
    Histochem Cell Biol; 2012 Aug; 138(2):251-69. PubMed ID: 22481617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Platelet-derived growth factor stimulates bone resorption by monocyte monolayers.
    Key LL; Carnes DL; Weichselbaum R; Anast CS
    Endocrinology; 1983 Feb; 112(2):761-2. PubMed ID: 6848370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Is reuse of autologous ear ossicles in cholesteatoma or chronic suppurative otitis media justified?].
    Peng JC; Hoppe F
    Laryngorhinootologie; 1994 Jul; 73(7):375-80. PubMed ID: 7916783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Current concepts of the pathogenesis of acquired middle ear cholesteatoma].
    Welkoborsky HJ
    Laryngorhinootologie; 2011 Jan; 90(1):38-48; quiz 49-50. PubMed ID: 21225533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.